{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,21]],"date-time":"2026-01-21T11:59:31Z","timestamp":1768996771557,"version":"3.49.0"},"reference-count":60,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2022,4,1]],"date-time":"2022-04-01T00:00:00Z","timestamp":1648771200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,4,1]],"date-time":"2022-04-01T00:00:00Z","timestamp":1648771200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2022,4,1]],"date-time":"2022-04-01T00:00:00Z","timestamp":1648771200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2022,4,1]],"date-time":"2022-04-01T00:00:00Z","timestamp":1648771200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2022,4,1]],"date-time":"2022-04-01T00:00:00Z","timestamp":1648771200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2022,4,1]],"date-time":"2022-04-01T00:00:00Z","timestamp":1648771200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2022,4,1]],"date-time":"2022-04-01T00:00:00Z","timestamp":1648771200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Trends in Cardiovascular Medicine"],"published-print":{"date-parts":[[2022,4]]},"DOI":"10.1016\/j.tcm.2021.02.006","type":"journal-article","created":{"date-parts":[[2021,2,22]],"date-time":"2021-02-22T20:03:52Z","timestamp":1614024232000},"page":"163-169","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":5,"title":["Coronary revascularization in patients with HIV"],"prefix":"10.1016","volume":"32","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-3265-1620","authenticated-orcid":false,"given":"Keir","family":"McCutcheon","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8037-463X","authenticated-orcid":false,"given":"Andreas S.","family":"Triantafyllis","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5606-376X","authenticated-orcid":false,"given":"Jef","family":"Van den Eynde","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8313-3559","authenticated-orcid":false,"given":"Wouter","family":"Oosterlinck","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ahmed","family":"Vachiat","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7210-1447","authenticated-orcid":false,"given":"Nqoba","family":"Tsabedze","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Don","family":"Zachariah","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Pravin","family":"Manga","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8301-4517","authenticated-orcid":false,"given":"Johan","family":"Bennett","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.tcm.2021.02.006_bib0001","unstructured":"UNAIDS. Global HIV & AIDS statistics \u2014 2019 fact sheet. https:\/\/www.unaids.org\/en\/resources\/fact-sheet. Accessed 18 January 2021."},{"issue":"1","key":"10.1016\/j.tcm.2021.02.006_bib0002","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1016\/j.jacc.2016.09.979","article-title":"HIV and ischemic heart disease","volume":"69","author":"Vachiat","year":"2017","journal-title":"J Am Coll Cardiol"},{"issue":"8","key":"10.1016\/j.tcm.2021.02.006_bib0003","doi-asserted-by":"crossref","first-page":"1078","DOI":"10.1016\/j.amjcard.2012.05.045","article-title":"Comparison of in-hospital mortality from acute myocardial infarction in HIV sero-positive versus sero-negative individuals","volume":"110","author":"Pearce","year":"2012","journal-title":"Am J Cardiol"},{"issue":"11","key":"10.1016\/j.tcm.2021.02.006_bib0004","doi-asserted-by":"crossref","first-page":"1100","DOI":"10.1161\/CIRCULATIONAHA.117.033369","article-title":"Global burden of atherosclerotic cardiovascular disease in people living with HIV: systematic review and meta-analysis","volume":"138","author":"Shah","year":"2018","journal-title":"Circulation"},{"issue":"7","key":"10.1016\/j.tcm.2021.02.006_bib0005","doi-asserted-by":"crossref","first-page":"2506","DOI":"10.1210\/jc.2006-2190","article-title":"Increased acute myocardial infarction rates and cardiovascular risk factors among patients with human immunodeficiency virus disease","volume":"92","author":"Triant","year":"2007","journal-title":"J Clin Endocrinol Metab"},{"issue":"8","key":"10.1016\/j.tcm.2021.02.006_bib0006","doi-asserted-by":"crossref","first-page":"614","DOI":"10.1001\/jamainternmed.2013.3728","article-title":"HIV infection and the risk of acute myocardial infarction","volume":"173","author":"Freiberg","year":"2013","journal-title":"JAMA Intern Med"},{"issue":"8","key":"10.1016\/j.tcm.2021.02.006_bib0007","doi-asserted-by":"crossref","first-page":"1228","DOI":"10.1097\/QAD.0b013e328339192f","article-title":"Increased risk of myocardial infarction in HIV-infected patients in France, relative to the general population","volume":"24","author":"Lang","year":"2010","journal-title":"AIDS"},{"issue":"2","key":"10.1016\/j.tcm.2021.02.006_bib0008","doi-asserted-by":"crossref","first-page":"160","DOI":"10.1097\/QAI.0000000000000009","article-title":"Immunodeficiency and risk of myocardial infarction among HIV-positive individuals with access to care","volume":"65","author":"Silverberg","year":"2014","journal-title":"J Acquir Immune Defic Syndr (1999)"},{"issue":"21","key":"10.1016\/j.tcm.2021.02.006_bib0009","doi-asserted-by":"crossref","first-page":"1993","DOI":"10.1056\/NEJMoa030218","article-title":"Combination antiretroviral therapy and the risk of myocardial infarction","volume":"349","author":"Friis-Moller","year":"2003","journal-title":"N Engl J Med"},{"issue":"8","key":"10.1016\/j.tcm.2021.02.006_bib0010","doi-asserted-by":"crossref","first-page":"1074","DOI":"10.1086\/521935","article-title":"Ten-year predicted coronary heart disease risk in HIV-infected men and women","volume":"45","author":"Kaplan","year":"2007","journal-title":"Clin Infect Dis"},{"issue":"3","key":"10.1016\/j.tcm.2021.02.006_bib0011","doi-asserted-by":"crossref","first-page":"308","DOI":"10.1097\/QAI.0000000000001606","article-title":"Abdominal fat depots and subclinical carotid artery atherosclerosis in women with and without HIV infection","volume":"77","author":"Glesby","year":"2018","journal-title":"J Acquir Immune Defic Syndr"},{"issue":"2","key":"10.1016\/j.tcm.2021.02.006_bib0012","doi-asserted-by":"crossref","first-page":"214","DOI":"10.1177\/2047487315579291","article-title":"An updated prediction model of the global risk of cardiovascular disease in HIV-positive persons: the data-collection on adverse effects of anti-HIV drugs (D:A:D) study","volume":"23","author":"Friis-Moller","year":"2016","journal-title":"Eur J Prevent Cardiol"},{"key":"10.1016\/j.tcm.2021.02.006_bib0013","doi-asserted-by":"crossref","DOI":"10.1155\/2018\/6916497","article-title":"Risk factors, and pathophysiology of dysglycemia among people living with HIV in Sub-Saharan Africa","volume":"2018","author":"Njuguna","year":"2018","journal-title":"J Diabetes Res"},{"issue":"2","key":"10.1016\/j.tcm.2021.02.006_bib0014","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1097\/QAD.0000000000001700","article-title":"High rates of hypertension, diabetes, elevated low-density lipoprotein cholesterol, and cardiovascular disease risk factors in HIV-infected patients in Malawi","volume":"32","author":"Mathabire Rucker","year":"2018","journal-title":"AIDS"},{"key":"10.1016\/j.tcm.2021.02.006_bib0015","doi-asserted-by":"crossref","first-page":"e7","DOI":"10.1017\/gheg.2018.7","article-title":"HIV treatment is associated with a two-fold higher probability of raised triglycerides: pooled analyses in 21 023 individuals in sub-Saharan Africa","volume":"3","author":"Ekoru","year":"2018","journal-title":"Glob Health Epidemiol Genom"},{"issue":"7","key":"10.1016\/j.tcm.2021.02.006_bib0016","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0201404","article-title":"The association between antiretroviral therapy and selected cardiovascular disease risk factors in sub-Saharan Africa: a systematic review and meta-analysis","volume":"13","author":"Dimala","year":"2018","journal-title":"PLoS One"},{"issue":"3","key":"10.1016\/j.tcm.2021.02.006_bib0017","doi-asserted-by":"crossref","first-page":"318","DOI":"10.1086\/649897","article-title":"Risk of myocardial infarction in patients with HIV infection exposed to specific individual antiretroviral drugs from the 3 major drug classes: the data collection on adverse events of anti-HIV drugs (D:A:D) study","volume":"201","author":"Worm","year":"2010","journal-title":"J Infect Dis"},{"issue":"9","key":"10.1016\/j.tcm.2021.02.006_bib0018","doi-asserted-by":"crossref","first-page":"1878","DOI":"10.1093\/jac\/dkq231","article-title":"Lipid profiles in HIV-infected adults receiving atazanavir and atazanavir\/ritonavir: systematic review and meta-analysis of randomized controlled trials","volume":"65","author":"Carey","year":"2010","journal-title":"J Antimicrob Chemother"},{"issue":"9712","key":"10.1016\/j.tcm.2021.02.006_bib0019","doi-asserted-by":"crossref","first-page":"396","DOI":"10.1016\/S0140-6736(09)62041-9","article-title":"Switch to a raltegravir-based regimen versus continuation of a lopinavir-ritonavir-based regimen in stable HIV-infected patients with suppressed viraemia (SWITCHMRK 1 and 2): two multicentre, double-blind, randomised controlled trials","volume":"375","author":"Eron","year":"2010","journal-title":"Lancet"},{"issue":"21","key":"10.1016\/j.tcm.2021.02.006_bib0020","first-page":"1676","article-title":"Platelet reactivity in human immunodeficiency virus infected patients on dual antiplatelet therapy for an acute coronary syndrome: the EVERE2ST-HIV study","volume":"38","author":"Hauguel-Moreau","year":"2017","journal-title":"Eur Heart J"},{"issue":"3","key":"10.1016\/j.tcm.2021.02.006_bib0021","doi-asserted-by":"crossref","first-page":"206","DOI":"10.1016\/j.acvd.2015.01.004","article-title":"Epidemiology of coronary heart disease in HIV-infected versus uninfected individuals in developed countries","volume":"108","author":"Lang","year":"2015","journal-title":"Arch Cardiovasc Dis"},{"issue":"9","key":"10.1016\/j.tcm.2021.02.006_bib0022","doi-asserted-by":"crossref","first-page":"1413","DOI":"10.1097\/QAD.0000000000001063","article-title":"Association of increased CD8+ and persisting C-reactive protein levels with restenosis in HIV patients after coronary stenting","volume":"30","author":"Schneider","year":"2016","journal-title":"AIDS"},{"issue":"3","key":"10.1016\/j.tcm.2021.02.006_bib0023","doi-asserted-by":"crossref","first-page":"558","DOI":"10.1016\/j.thromres.2014.05.037","article-title":"Prognostic indicators for recurrent thrombotic events in HIV-infected patients with acute coronary syndromes: use of registry data from 12 sites in Europe, South Africa and the United States","volume":"134","author":"D\u2019Ascenzo","year":"2014","journal-title":"Thromb Res"},{"issue":"14","key":"10.1016\/j.tcm.2021.02.006_bib0024","doi-asserted-by":"crossref","first-page":"1757","DOI":"10.4244\/EIJ-D-15-00409","article-title":"Quantitative angiographic characterisation of coronary artery disease in patients with human immunodeficiency virus (HIV) infection undergoing percutaneous coronary intervention","volume":"12","author":"Theodoropoulos","year":"2017","journal-title":"EuroIntervention"},{"issue":"1","key":"10.1016\/j.tcm.2021.02.006_bib0025","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1111\/j.1540-8183.2009.00520.x","article-title":"Acute coronary syndromes in treatment-naive black South africans with human immunodeficiency virus infection","volume":"23","author":"Becker","year":"2010","journal-title":"J Interv Cardiol"},{"issue":"12","key":"10.1016\/j.tcm.2021.02.006_bib0026","doi-asserted-by":"crossref","first-page":"745","DOI":"10.1038\/s41569-019-0219-9","article-title":"HIV infection and coronary heart disease: mechanisms and management","volume":"16","author":"Hsue","year":"2019","journal-title":"Nat Rev Cardiol"},{"issue":"4","key":"10.1016\/j.tcm.2021.02.006_bib0027","doi-asserted-by":"crossref","first-page":"203","DOI":"10.5830\/CVJA-2019-016","article-title":"Atherosclerotic plaque in HIV-positive patients presenting with acute coronary syndromes","volume":"30","author":"Vachiat","year":"2019","journal-title":"Cardiovasc J Afr"},{"issue":"5","key":"10.1016\/j.tcm.2021.02.006_bib0028","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1111\/joic.12433","article-title":"Coronary revascularization for acute myocardial infarction in the HIV population","volume":"30","author":"Singh","year":"2017","journal-title":"J Interv Cardiol"},{"issue":"10","key":"10.1016\/j.tcm.2021.02.006_bib0029","first-page":"403","article-title":"Influence of human immunodeficiency virus seropositive status on the in-hospital management and outcomes of patients presenting with acute myocardial infarction","volume":"28","author":"Smilowitz","year":"2016","journal-title":"J Invasive Cardiol"},{"issue":"5","key":"10.1016\/j.tcm.2021.02.006_bib0030","doi-asserted-by":"crossref","first-page":"321","DOI":"10.2459\/JCM.0000000000000767","article-title":"In-hospital and long-term outcomes of HIV-positive patients undergoing PCI according to kind of stent: a meta-analysis","volume":"20","author":"Peyracchia","year":"2019","journal-title":"J Cardiovasc Med"},{"issue":"2","key":"10.1016\/j.tcm.2021.02.006_bib0031","doi-asserted-by":"crossref","first-page":"216","DOI":"10.1016\/j.amjcard.2009.03.036","article-title":"Comparison of outcomes using bare metal versus drug-eluting stents in coronary artery disease patients with and without human immunodeficiency virus infection","volume":"104","author":"Ren","year":"2009","journal-title":"Am J Cardiol"},{"issue":"10","key":"10.1016\/j.tcm.2021.02.006_bib0032","doi-asserted-by":"crossref","first-page":"e177","DOI":"10.1016\/j.jacc.2019.03.010","article-title":"2019 ACC\/AHA guideline on the primary prevention of cardiovascular disease: a report of the American College of Cardiology\/American Heart Association task force on clinical practice guidelines","volume":"74","author":"Arnett","year":"2019","journal-title":"J Am Coll Cardiol"},{"issue":"1","key":"10.1016\/j.tcm.2021.02.006_bib0033","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1186\/s12981-019-0226-2","article-title":"Statins and aspirin in the prevention of cardiovascular disease among HIV-positive patients between controversies and unmet needs: review of the literature and suggestions for a friendly use","volume":"16","author":"Maggi","year":"2019","journal-title":"AIDS Res Ther"},{"issue":"2","key":"10.1016\/j.tcm.2021.02.006_bib0034","doi-asserted-by":"crossref","first-page":"e98","DOI":"10.1161\/CIR.0000000000000695","article-title":"Characteristics, prevention, and management of cardiovascular disease in people living with HIV: a scientific statement from the American Heart Association","volume":"140","author":"Feinstein","year":"2019","journal-title":"Circulation"},{"issue":"3","key":"10.1016\/j.tcm.2021.02.006_bib0035","doi-asserted-by":"crossref","first-page":"ofu076","DOI":"10.1093\/ofid\/ofu076","article-title":"Aspirin use for primary and secondary prevention in human immunodeficiency virus (HIV)-infected and HIV-uninfected patients","volume":"1","author":"Suchindran","year":"2014","journal-title":"Open Forum Infect Dis"},{"issue":"3","key":"10.1016\/j.tcm.2021.02.006_bib0036","doi-asserted-by":"crossref","first-page":"280","DOI":"10.1097\/QAI.0b013e31828a292c","article-title":"Aspirin attenuates platelet activation and immune activation in HIV-1-infected subjects on antiretroviral therapy: a pilot study","volume":"63","author":"O\u2019Brien","year":"2013","journal-title":"J Acquir Immune Defic Syndr"},{"issue":"1","key":"10.1016\/j.tcm.2021.02.006_bib0037","doi-asserted-by":"crossref","first-page":"ofw278","DOI":"10.1093\/ofid\/ofw278","article-title":"A randomized placebo controlled trial of aspirin effects on immune activation in chronically human immunodeficiency virus-infected adults on virologically suppressive antiretroviral therapy","volume":"4","author":"O\u2019Brien","year":"2017","journal-title":"Open Forum Infect Dis"},{"issue":"16","key":"10.1016\/j.tcm.2021.02.006_bib0038","doi-asserted-by":"crossref","first-page":"1524","DOI":"10.1056\/NEJMoa1908973","article-title":"Ticagrelor or Prasugrel in patients with acute coronary syndromes","volume":"381","author":"Schupke","year":"2019","journal-title":"N Engl J Med"},{"issue":"11","key":"10.1016\/j.tcm.2021.02.006_bib0039","doi-asserted-by":"crossref","first-page":"1584","DOI":"10.1016\/j.metabol.2011.03.015","article-title":"Ritonavir inhibits the two main prasugrel bioactivation pathways in vitro: a potential drug-drug interaction in HIV patients","volume":"60","author":"Daali","year":"2011","journal-title":"Metabolism"},{"issue":"4","key":"10.1016\/j.tcm.2021.02.006_bib0040","doi-asserted-by":"crossref","first-page":"703","DOI":"10.1124\/dmd.110.037143","article-title":"In vitro evaluation of potential drug-drug interactions with ticagrelor: cytochrome P450 reaction phenotyping, inhibition, induction, and differential kinetics","volume":"39","author":"Zhou","year":"2011","journal-title":"Drug Metab Disposition"},{"issue":"7","key":"10.1016\/j.tcm.2021.02.006_bib0041","doi-asserted-by":"crossref","first-page":"810","DOI":"10.1016\/S1473-3099(15)00056-0","article-title":"Future challenges for clinical care of an ageing population infected with HIV: a modelling study","volume":"15","author":"Smit","year":"2015","journal-title":"Lancet Infect Dis"},{"issue":"1","key":"10.1016\/j.tcm.2021.02.006_bib0042","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1093\/eurheartj\/ehq372","article-title":"Acute coronary syndrome in human immunodeficiency virus-infected patients: characteristics and 1 year prognosis","volume":"32","author":"Boccara","year":"2011","journal-title":"Eur Heart J"},{"issue":"4","key":"10.1016\/j.tcm.2021.02.006_bib0043","doi-asserted-by":"crossref","first-page":"543","DOI":"10.1136\/hrt.2005.068445","article-title":"Percutaneous coronary intervention in HIV infected patients: immediate results and long term prognosis","volume":"92","author":"Boccara","year":"2006","journal-title":"Heart"},{"issue":"17","key":"10.1016\/j.tcm.2021.02.006_bib0044","doi-asserted-by":"crossref","first-page":"1767","DOI":"10.1161\/CIRCULATIONAHA.113.001874","article-title":"Outcomes after acute myocardial infarction in HIV-infected patients: analysis of data from a French nationwide hospital medical information database","volume":"127","author":"Lorgis","year":"2013","journal-title":"Circulation"},{"issue":"2","key":"10.1016\/j.tcm.2021.02.006_bib0045","first-page":"192","article-title":"Safety and long-term outcomes after percutaneous coronary intervention in patients with human immunodeficiency virus","volume":"85","author":"Badr","year":"2015","journal-title":"Catheterization Cardiovasc Interv"},{"issue":"1","key":"10.1016\/j.tcm.2021.02.006_bib0046","doi-asserted-by":"crossref","first-page":"190","DOI":"10.1186\/s12872-017-0624-0","article-title":"Does infection with human immunodeficiency virus have any impact on the cardiovascular outcomes following percutaneous coronary intervention?: a systematic review and meta-analysis","volume":"17","author":"Bundhun","year":"2017","journal-title":"BMC Cardiovasc Disord"},{"issue":"6","key":"10.1016\/j.tcm.2021.02.006_bib0047","first-page":"879","article-title":"Outcome of percutaneous coronary intervention in HIV-infected patients","volume":"68","author":"Segev","year":"2006","journal-title":"Catheterization Cardiovasc Interv"},{"issue":"1","key":"10.1016\/j.tcm.2021.02.006_bib0048","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1111\/hiv.12670","article-title":"Recurrence after hospitalization for acute coronary syndrome among HIV-infected and HIV-uninfected individuals","volume":"20","author":"Marcus","year":"2019","journal-title":"HIV Med"},{"issue":"4","key":"10.1016\/j.tcm.2021.02.006_bib0049","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1001\/archinte.163.4.457","article-title":"Acute myocardial infarction in human immunodeficiency virus-infected patients","volume":"163","author":"Matetzky","year":"2003","journal-title":"Arch Intern Med"},{"issue":"47","key":"10.1016\/j.tcm.2021.02.006_bib0050","doi-asserted-by":"crossref","first-page":"3320","DOI":"10.1093\/eurheartj\/ehv511","article-title":"Stent thrombosis and restenosis: what have we learned and where are we going? The Andreas Gr\u00fcntzig Lecture ESC 2014","volume":"36","author":"Byrne","year":"2015","journal-title":"Eur Heart J"},{"issue":"1","key":"10.1016\/j.tcm.2021.02.006_bib0051","doi-asserted-by":"crossref","first-page":"59","DOI":"10.2174\/157016208783571900","article-title":"Coronary artery bypass graft in HIV-infected patients: a multicenter case control study","volume":"6","author":"Boccara","year":"2008","journal-title":"Curr HIV Res"},{"issue":"3","key":"10.1016\/j.tcm.2021.02.006_bib0052","first-page":"320","article-title":"Cardiac surgery in HIV patients: state of the art","volume":"35","author":"Yanagawa","year":"2019","journal-title":"Can J Cardiol"},{"key":"10.1016\/j.tcm.2021.02.006_bib0053","article-title":"Heart team 2.0: a decision tree for minimally invasive and hybrid myocardial revascularization","author":"Van den Eynde","year":"2020","journal-title":"Trends Cardiovasc Med"},{"key":"10.1016\/j.tcm.2021.02.006_bib0054","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1016\/j.ahj.2018.12.016","article-title":"Rationale and design of the randomized trial to prevent vascular events in HIV (REPRIEVE)","volume":"212","author":"Grinspoon","year":"2019","journal-title":"Am Heart J"},{"issue":"1","key":"10.1016\/j.tcm.2021.02.006_bib0055","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1080\/25787489.2020.1733794","article-title":"Successful recruitment of a multi-site international randomized placebo-controlled trial in people with HIV with attention to diversity of race and ethnicity: critical role of central coordination","volume":"21","author":"Fitch","year":"2020","journal-title":"HIV Res Clin Pract"},{"issue":"48","key":"10.1016\/j.tcm.2021.02.006_bib0056","doi-asserted-by":"crossref","first-page":"3600","DOI":"10.1093\/eurheartj\/ehv734","article-title":"Comparative safety and efficacy of statins for primary prevention in human immunodeficiency virus-positive patients: a systematic review and meta-analysis","volume":"37","author":"Gili","year":"2016","journal-title":"Eur Heart J"},{"issue":"3","key":"10.1016\/j.tcm.2021.02.006_bib0057","first-page":"326","article-title":"Getting to the heart of the matter: a review of drug interactions between HIV antiretrovirals and cardiology medications","volume":"35","author":"Giguere","year":"2019","journal-title":"Can J Cardiol"},{"issue":"12","key":"10.1016\/j.tcm.2021.02.006_bib0058","doi-asserted-by":"crossref","first-page":"1760","DOI":"10.1016\/j.amjcard.2015.03.025","article-title":"A systematic review of the usefulness of statin therapy in HIV-infected patients","volume":"115","author":"Feinstein","year":"2015","journal-title":"Am J Cardiol"},{"issue":"5","key":"10.1016\/j.tcm.2021.02.006_bib0059","doi-asserted-by":"crossref","first-page":"613","DOI":"10.1086\/378131","volume":"37","author":"Dub\u00e9","year":"2003","journal-title":"Clin Infect Dis"},{"issue":"6","key":"10.1016\/j.tcm.2021.02.006_bib0060","doi-asserted-by":"crossref","first-page":"605","DOI":"10.1097\/FJC.0b013e31817b5b5a","article-title":"Effects of atazanavir\/ritonavir or fosamprenavir\/ritonavir on the pharmacokinetics of rosuvastatin","volume":"51","author":"Busti","year":"2008","journal-title":"J Cardiovasc Pharmacol"}],"container-title":["Trends in Cardiovascular Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S105017382100027X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S105017382100027X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,20]],"date-time":"2025-10-20T05:01:59Z","timestamp":1760936519000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S105017382100027X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,4]]},"references-count":60,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2022,4]]}},"alternative-id":["S105017382100027X"],"URL":"https:\/\/doi.org\/10.1016\/j.tcm.2021.02.006","relation":{},"ISSN":["1050-1738"],"issn-type":[{"value":"1050-1738","type":"print"}],"subject":[],"published":{"date-parts":[[2022,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Coronary revascularization in patients with HIV","name":"articletitle","label":"Article Title"},{"value":"Trends in Cardiovascular Medicine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.tcm.2021.02.006","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}